Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN, Fischer WA 2nd, Garry RF, Grant DS, Happi C, N'Faly M, Olayinka A, Samuels R, Sibley J, Wohl DA, Accrombessi M, Adetifa I, Annibaldis G, Camacho A, Dan-Nwafor C, Deha ARE, DeMarco J, Duraffour S, Goba A, Grais R, Günther S, Honvou ÉJJP, Ihekweazu C, Jacobsen C, Kanneh L, Momoh M, Ndiaye A, Nsaibirni R, Okogbenin S, Ochu C, Ogbaini E, Logbo ÉPMA, Sandi JD, Schieffelin JS, Verstraeten T, Vielle NJ, Yadouleton A, Yovo EK; Enable Protocol authorship group. Penfold S, et al. Among authors: grais r. PLoS One. 2023 Mar 30;18(3):e0283643. doi: 10.1371/journal.pone.0283643. eCollection 2023. PLoS One. 2023. PMID: 36996258 Free PMC article.
Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad.
Grais RF, Dubray C, Gerstl S, Guthmann JP, Djibo A, Nargaye KD, Coker J, Alberti KP, Cochet A, Ihekweazu C, Nathan N, Payne L, Porten K, Sauvageot D, Schimmer B, Fermon F, Burny ME, Hersh BS, Guerin PJ. Grais RF, et al. PLoS Med. 2007 Jan;4(1):e16. doi: 10.1371/journal.pmed.0040016. PLoS Med. 2007. PMID: 17199407 Free PMC article.
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.
Simon JK, Kennedy SB, Mahon BE, Dubey SA, Grant-Klein RJ, Liu K, Hartzel J, Coller BG, Welebob C, Hanson ME, Grais RF. Simon JK, et al. Vaccine. 2022 Nov 2;40(46):6599-6606. doi: 10.1016/j.vaccine.2022.09.037. Epub 2022 Oct 5. Vaccine. 2022. PMID: 36208978 Clinical Trial.
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
Watson-Jones D, Kavunga-Membo H, Grais RF, Ahuka S, Roberts N, Edmunds WJ, Choi EM, Roberts CH, Edwards T, Camacho A, Lees S, Leyssen M, Spiessens B, Luhn K, Douoguih M, Hatchett R, Bausch DG, Muyembe JJ; DRC-EB-001 protocol writing team. Watson-Jones D, et al. Among authors: grais rf. BMJ Open. 2022 Mar 8;12(3):e055596. doi: 10.1136/bmjopen-2021-055596. BMJ Open. 2022. PMID: 35260458 Free PMC article.
Using simulation to aid trial design: Ring-vaccination trials.
Hitchings MD, Grais RF, Lipsitch M. Hitchings MD, et al. PLoS Negl Trop Dis. 2017 Mar 22;11(3):e0005470. doi: 10.1371/journal.pntd.0005470. eCollection 2017 Mar. PLoS Negl Trop Dis. 2017. PMID: 28328984 Free PMC article.
Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study.
Grout L, Martinez-Pino I, Ciglenecki I, Keita S, Diallo AA, Traore B, Delamou D, Toure O, Nicholas S, Rusch B, Staderini N, Serafini M, Grais RF, Luquero FJ. Grout L, et al. PLoS Negl Trop Dis. 2015 Dec 29;9(12):e0004274. doi: 10.1371/journal.pntd.0004274. eCollection 2015 Dec. PLoS Negl Trop Dis. 2015. PMID: 26713614 Free PMC article.
218 results